|
Fatty acids
|
Controls
|
HCV pretreatment patients
|
HCV post treatment patients
|
|---|
|
C – 14:0
|
1.1 ± 3.2a
|
2.8 ± 1.7b
|
1.9 ± 0.7c
|
|
C - 16 : 0
|
23.9 ± 5.3a
|
26.6 ± 3.8b
|
27.8 ± 2.3c
|
|
C - 18 : 0
|
14.7 ± 5.4
|
15.4 ± 5.12
|
12.3 ± 3.1
|
|
C - 20 : 0
|
0.4 ± 1.1
|
0.3 ± 0.9
|
0.4 ± 0.8
|
|
C - 14 : 1
|
0.5 ± 0.9
|
0.3 ± 2.2
|
0.4 ± 0.4
|
|
C - 16 : 1
|
2.6 ± 2.2
|
3.2 ± 1.4
|
3.8 ± 1.1
|
|
C - 18 : 1
|
19.8 ± 4.6
|
19.6 ± 3.6
|
20.9 ± 1.8
|
|
C - 22 : 1
|
1.9 ± 1.4
|
2.7 ± 1.4
|
2.3 ± 0.8
|
|
C – 24 : 1
|
0.3 ± 0.7
|
ND
|
ND
|
|
C - 18 : 2
|
25.0 ± 5.4a
|
20.9 ± 5.8b
|
21.6 ± 4.1c
|
|
C - 18 : 3
|
0.8 ± 1.3
|
0.3 ± 1.0
|
0.7 ± 0.9
|
|
C - 20 : 4
|
5.9 ± 2.1
|
5.1 ± 1.6
|
5.3 ± 0.8
|
|
C - 20 : 5
|
0.9 ± 1.7
|
0.6 ± 1.3
|
0.5 ± 0.9
|
|
C - 20 : 3
|
0.4 ± 0.6
|
0.2 ± 0.9
|
ND
|
|
C - 22 : 6
|
0.39 ± 0.7
|
ND
|
ND
|
|
C-18:1: C-18:0
|
1.3
|
1.3
|
1.7
|
|
C-16:1: C-16:0
|
0.1
|
0.2
|
0.3
|
|
PUFA: SFA
|
1.0
|
0.6
|
0.8
|
- Values represent mean ± Standard deviation of triplicates. Different alphabets on the same row indicate significant difference at p <0.05. myristic acid (C14:0), myristoleic acid (C14:1), palmitic acid (C16:0), palmitoleic acid (C16:1), stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2), α-linolenic acid (C18:3), arachidic acid (C20:0), eicosatrienoic acid (C-20:3), arachidonic acid (C20:4), eicosapentaenoic acid (EPA (C20:5), docosenoic acid (C22:1), docosahexaenoic acid (DHA (C22:6), nervonic acid(C24:1), not detected (ND)
